Search research articles
Contact Us
Filters
Showing results (681-690 of 762) with videos related to
Page
of 77
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2018
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial
Christos E Kyriakopoulos, Yu-Hui Chen, Michael A Carducci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 14, 2014
Neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin with pegfilgrastim support in muscle-invasive urothelial cancer: pathologic, radiologic, and biomarker correlates
Toni K Choueiri, Susanna Jacobus, Joaquim Bellmunt, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 7, 2024
Stereotactic Body Proton Therapy Versus Conventionally Fractionated Proton Therapy for Early Prostate Cancer: A Randomized, Controlled, Phase 3 Trial
Diego A S Toesca, William F Hartsell, Todd A DeWees, et al.
European Urology
|
March 4, 2019
Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis
Sarah Burdett, Liselotte M Boevé, Fiona C Ingleby, et al.
Journal of Geriatric Oncology
|
May 28, 2014
Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancer
Brandon A Mahal, David R Ziehr, Ayal A Aizer, et al.
Nature Medicine
|
January 11, 2022
Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial
Thomas Powles, Kobe C Yuen, Silke Gillessen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2015
Brain Metastases in Patients With Germ Cell Tumors: Prognostic Factors and Treatment Options--An Analysis From the Global Germ Cell Cancer Group
Darren R Feldman, Anja Lorch, Andrew Kramar, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 12, 2004
Benzimidazolone p38 inhibitors
Mark A Dombroski, Michael A Letavic, Kim F McClure, et al.
Current Controlled Trials in Cardiovascular Medicine
|
July 5, 2002
A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline Characteristics
Ian Ford, Gerard Jan Blauw, Michael B Murphy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 2022
Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer
Christopher J Sweeney, Ivor J Percent, Sunil Babu, et al.
Page
of 77
Search research articles
Search
Showing results (681-690 of 762) with videos related to
Sort By:
Page
of 77
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2018
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial
Christos E Kyriakopoulos, Yu-Hui Chen, Michael A Carducci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 14, 2014
Neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin with pegfilgrastim support in muscle-invasive urothelial cancer: pathologic, radiologic, and biomarker correlates
Toni K Choueiri, Susanna Jacobus, Joaquim Bellmunt, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 7, 2024
Stereotactic Body Proton Therapy Versus Conventionally Fractionated Proton Therapy for Early Prostate Cancer: A Randomized, Controlled, Phase 3 Trial
Diego A S Toesca, William F Hartsell, Todd A DeWees, et al.
European Urology
|
March 4, 2019
Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis
Sarah Burdett, Liselotte M Boevé, Fiona C Ingleby, et al.
Journal of Geriatric Oncology
|
May 28, 2014
Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancer
Brandon A Mahal, David R Ziehr, Ayal A Aizer, et al.
Nature Medicine
|
January 11, 2022
Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial
Thomas Powles, Kobe C Yuen, Silke Gillessen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2015
Brain Metastases in Patients With Germ Cell Tumors: Prognostic Factors and Treatment Options--An Analysis From the Global Germ Cell Cancer Group
Darren R Feldman, Anja Lorch, Andrew Kramar, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 12, 2004
Benzimidazolone p38 inhibitors
Mark A Dombroski, Michael A Letavic, Kim F McClure, et al.
Current Controlled Trials in Cardiovascular Medicine
|
July 5, 2002
A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline Characteristics
Ian Ford, Gerard Jan Blauw, Michael B Murphy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 2022
Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer
Christopher J Sweeney, Ivor J Percent, Sunil Babu, et al.
Page
of 77